Matthew Clark

Keyphrases

1. Binding Energy 100%
2. Clinical Adverse Events 78%
3. Adverse Events 74%
4. Fragment-based 67%
5. Virtual Control Groups 63%
6. Ab Initio Study 63%
7. Methyl 63%
8. Respiratory Safety 63%
9. Core Battery 63%
10. Safety Pharmacology 63%
11. Comparative Molecular Field Analysis (CoMFA) 52%
12. Clinical Trials 51%
13. Partial Least Squares Structural Equation Modeling (PLS-SEM) 51%
14. Respiratory Adverse Events 47%
15. Isomerization 47%
16. Ab Initio Calculations 47%
17. Transition State 47%
18. Nonclinical 47%
19. Drug Development 47%
20. Pharmacology Studies 47%
21. Marketed Drugs 45%
22. Concurrent Control 42%
23. Grand Canonical 42%
24. First-in-human 39%
25. Chance Correlation 39%
26. ICH S7A 39%
27. Predictive Model 37%
28. Molecular Structure 37%
29. HERG 37%
30. Solvation 36%
31. Approved Drugs 36%
32. Cytochrome P450 46A1 35%
33. CRISTAL 35%
34. Drug Discovery 35%
35. Drug-induced 31%
36. Structural Database 31%
37. Historical Control 31%
38. Torsades-de-Pointes 31%
39. Nausea 31%
40. Data Mining Applications 31%
41. Data Visualization Techniques 31%
42. Data Mining Techniques 31%
43. Multi-company 31%
44. Nonclinical Safety 31%
45. Molecular Orbital Package (MOPAC) 31%
46. N-trifluoromethyl 31%
47. Hydrogen Bond (H-bond) 31%
48. Gaussian Software 31%
49. Interconversion 31%
50. Formamide 31%